Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium in Aneurysmal Subarachnoid Haemorrhage
2006-003523-36Phase 3Unknown
- Sponsor
- Nederlandse Hartstichting
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of magnesium sulfate in subarachnoid hemorrhage (SAH), sponsored by Nederlandse Hartstichting. Primary endpoint: Poor outcome at 3 months by modified Rankin Scale. Status: unknown.
02
Drugs
magnesium sulfate
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2006-003523-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003523-36.